-
Something wrong with this record ?
HIV-1 protease mutations and inhibitor modifications monitored on a series of complexes. Structural basis for the effect of the A71V mutation on the active site
Skálová T., Dohnálek J., Dušková J., Petroková H., Hradilek M., Souček M., Konvalinka J., Hašek J.
Language English Country United States
PubMed
16970402
DOI
10.1021/jm0605583
Knihovny.cz E-resources
- MeSH
- Ethanolamine chemistry MeSH
- Financing, Organized MeSH
- HIV Protease genetics chemistry MeSH
- HIV Protease Inhibitors chemistry MeSH
- Crystallography, X-Ray MeSH
- Ligands MeSH
- Models, Molecular MeSH
- Molecular Structure MeSH
- Mutation MeSH
- Oligopeptides chemistry MeSH
- Binding Sites MeSH
- Hydrogen Bonding MeSH
- Structure-Activity Relationship MeSH
Two new X-ray structures of an HIV-1 protease mutant (A71V, V82T, I84V) in complex with inhibitors SE and SQ, pseudotetrapeptide inhibitors with an acyclic S-hydroxyethylamine isostere, were determined. Comparison of eight structures exploring the binding of four similar inhibitors--SE, SQ (S-hydroxyethylamine isostere), OE (ethyleneamine), and QF34 (hydroxyethylene)--to wild-type and A71V/V82T/I84V HIV-1 protease elucidates the principles of altered interaction with changing conditions. The A71V mutation, which is distant from the active site, causes changes in the structure of the enzyme detectable by the means of X-ray structure analysis, and a route of propagation of the effect toward the active site is proposed.
References provided by Crossref.org
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07523584
- 003
- CZ-PrNML
- 005
- 20120508130132.0
- 008
- 090522s2006 xxu e eng||
- 009
- AR
- 024 __
- $a 10.1021/jm0605583 $2 doi
- 035 __
- $a (PubMed)16970402
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Skálová, Tereza $7 xx0119192
- 245 10
- $a HIV-1 protease mutations and inhibitor modifications monitored on a series of complexes. Structural basis for the effect of the A71V mutation on the active site / $c Skálová T., Dohnálek J., Dušková J., Petroková H., Hradilek M., Souček M., Konvalinka J., Hašek J.
- 314 __
- $a Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovského nam. 2, 162 06 Praha 6, Czech Republic. skalova@imc.cas.cz
- 520 9_
- $a Two new X-ray structures of an HIV-1 protease mutant (A71V, V82T, I84V) in complex with inhibitors SE and SQ, pseudotetrapeptide inhibitors with an acyclic S-hydroxyethylamine isostere, were determined. Comparison of eight structures exploring the binding of four similar inhibitors--SE, SQ (S-hydroxyethylamine isostere), OE (ethyleneamine), and QF34 (hydroxyethylene)--to wild-type and A71V/V82T/I84V HIV-1 protease elucidates the principles of altered interaction with changing conditions. The A71V mutation, which is distant from the active site, causes changes in the structure of the enzyme detectable by the means of X-ray structure analysis, and a route of propagation of the effect toward the active site is proposed.
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a krystalografie rentgenová $7 D018360
- 650 _2
- $a ethanolamin $x chemie $7 D019856
- 650 _2
- $a HIV-proteasa $x genetika $x chemie $7 D016333
- 650 _2
- $a inhibitory HIV-proteasy $x chemie $7 D017320
- 650 _2
- $a vodíková vazba $7 D006860
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a oligopeptidy $x chemie $7 D009842
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Dohnálek, Jan $7 xx0063750
- 700 1_
- $a Dušková, Jarmila. $7 xx0314967
- 700 1_
- $a Petroková, Hana $7 xx0119413
- 700 1_
- $a Hradilek, Martin $7 xx0076906
- 700 1_
- $a Souček, Milan, $d 1930- $7 jk01120477
- 700 1_
- $a Konvalinka, Jan, $d 1963- $7 mzk2004208597
- 700 1_
- $a Hašek, Jindřich, $d 1946- $7 mzk2006331646
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $g Roč. 49, č. 19 (2006), s. 5777-5784 $x 0022-2623
- 910 __
- $a ABA008 $b x $y 9
- 990 __
- $a 20090519102933 $b ABA008
- 991 __
- $a 20120508130120 $b ABA008
- 999 __
- $a ok $b bmc $g 656660 $s 509977
- BAS __
- $a 3
- BMC __
- $a 2006 $b 49 $c 19 $d 5777-5784 $i 0022-2623 $m Journal of medicinal chemistry $x MED00010049
- LZP __
- $a 2009-B2/dkme